Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Classificação em ações
#3509
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Preço da ação
$3.86
Valor de mercado
$4.88B
Variação (1 dia)
4.10%
Variação (1 ano)
-50.30%
País
CN
Negociar Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Categoria
Healthcare
Receita da Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Receita em Jun 2026 TTM: $293.29M
De acordo com os últimos relatórios financeiros da Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., a receita atual da empresa (TTM) é $293.29M. Em 2023, a empresa obteve uma receita de $778.51M uma diminuição em relação a a receita do ano 2022, que foi de $1.62B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. de 2013 a 2026
Receita no final de cada ano
| Ano | Receita | Alterar |
|---|---|---|
| 2026 (TTM) | $293.29M | -4.66% |
| 2024 | $307.63M | -60.49% |
| 2023 | $778.51M | -51.99% |
| 2022 | $1.62B | 79.23% |
| 2021 | $904.72M | 151.05% |
| 2020 | $360.38M | 111.99% |
| 2019 | $170.00M | 19.00% |
| 2018 | $142.86M | -2.11% |
| 2017 | $145.94M | 20.04% |
| 2016 | $121.57M | 15.98% |
| 2015 | $104.83M | 8.90% |
| 2014 | $96.26M | 17.00% |
| 2013 | $82.27M | 0.00% |
Receita de empresas similares ou concorrentes
| Empresa | Receita | Diferença de Receita | País |
|---|---|---|---|
| $12.62B | 4,204.41% |
US
|
|
| $2.23B | 659.66% |
US
|
|
| $15.74B | 5,268.23% |
AU
|
|
| $6.02B | 1,953.03% |
NL
|
|
| - | - |
CH
|
